表紙
市場調查報告書

全球生物晶片市場:產品種類,技術,用途,各地區 - 趨勢與預測

Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast to 2025

出版商 Coherent Market Insights 商品編碼 629666
出版日期 內容資訊 英文 152 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球生物晶片市場:產品種類,技術,用途,各地區 - 趨勢與預測 Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast to 2025
出版日期: 2018年04月03日內容資訊: 英文 152 Pages
簡介

本報告提供全球生物晶片市場相關調查分析,彙整各產品種類,技術,用途,各地區之市場部門考察,以及市場規模,成長率等相關資訊。

第1章 調查的目的與假設

  • 調查的目的
  • 假設
  • 簡稱

第2章 市場範圍

  • 報告的說明
  • 摘要整理
  • Coherent機會地圖(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
  • PEST分析
  • 波特的五力分析
  • Overlap- Lab-on-a-Chip,BioMEMS,µTAS

第4章 全球生物晶片市場:各產品種類

  • 簡介
  • DNA晶片
  • 蛋白質晶片
  • Lab-on-a-Chip
  • 其他(細胞陣列,組織陣列)

第5章 全球生物晶片市場:各技術

  • 簡介
  • 微流體
  • 微陣列

第6章 全球生物晶片市場:各用途

  • 簡介
  • 基因學
  • 蛋白質體學
  • 藥物研發,藥物開發
  • 體外診斷

第7章 全球生物晶片市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭情形

  • 熱圖分析
  • 企業簡介

第9章 章節

  • 參考資料
  • 調查方法
  • 關於本公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Biochip technology holds applications in areas such as diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. Microarray or biochip technology could prove beneficial, as prevalence of these diseases is increasing worldwide. Complexity of the technology, necessary resources in terms of manufacturing, and research and development of these products reflects in terms of high prices. Although the product helps in reducing costs incurred in laboratory methods, the biochip technology itself is still costly. Manufacturers and universities are focused on improving technology of the biochips in order to increase the precision of the results while lowering the costs and time. For instance, researchers from Stanford University School of Medicine had developed a method to produce cheap and reusable diagnostic lab-on-a-chip with the help of an inkjet printer, which was worth 1 cent per chip, in 2017.

Market Dynamics

Miniaturization of laboratory facilities to save time and costs and extensive product portfolios with wide number of applications of biochips offered by manufacturer’s drives growth of biochips market. Manufacturers offer technologically advanced products in order to minimize time and costs, and improve research outcomes. For instance, Micralyne, Inc. launched Silicon MicraFluidics technology, a line of standardized microfluidic process technologies, which enabled rapid design and deployment of microfluidic-based products in February 2018. Technological advancements in biochips platform, ongoing research and development to widen the applications, and advantages offered by biochip technologies over conventional laboratory with respect to time, costs, and ease of use is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of biochips market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global biochips market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biochips market

Detailed Segmentation:

  • Global Biochips Market, By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • Global Biochips Market, By Technology:
  • Microfluidics
  • Microarray
  • Global Biochips Market, By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • Global Biochips Market, By Geography:
  • North America
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
  • By Technology:
  • Microfluidics
  • Microarray   
  • By Application:
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Randox Laboratories*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Fluidigm Corporation
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ThermoFisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.
Back to Top